Medtech News
Boston Scientific Crashes After Cybersecurity Breach Forces 2026 Guidance Cut
Boston Scientific cut 2026 guidance after a cybersecurity attack disrupted operations
Oct 30, 2026
BsxBoston Scientific (BSX) Beats Q3 Earnings Amid Mixed FY26 Outlook
BSX beat Q3 estimates but issued cautious FY26 guidance; FARAPULSE driving electrophysiology growth while margin headwinds temper outlook.
Oct 29, 2026
๐บ๐ธ United StatesAbbott Q3 Earnings Beat on Diagnostics and MedTech Recovery, 2026 Guidance Intact
Abbott Laboratories (ABT) beat Q3 2026 EPS estimates, driven by recovery in diagnostics and cardiovascular device segments
Oct 22, 2026
๐บ๐ธ United StatesAROA Biosurgery Partners with Mรถlnlycke to Co-Promote Endoform in US Post-Acute Care Market
AROA Biosurgery and Mรถlnlycke Healthcare have entered an exclusive agreement to co-promote Endoform in US post-acute care settings
Oct 22, 2026
๐บ๐ธ United StatesJohnson & Johnson Q3 Earnings Beat Estimates but Shares Decline on MedTech Revenue Miss
Johnson & Johnson beat Q3 EPS estimates on pharmaceutical segment strength but shares fell after the MedTech division missed revenue expectations, with surgical robotics and orthopedics facing competitive headwinds and procedure volume softness.
Oct 14, 2026
๐ฆ๐บ AustraliaAroa Biosurgery's Symphony Randomized Controlled Trial Findings Carry Significant Commercial Implications, Webinar Reveals
Aroa Biosurgery presented findings and commercial implications of its Symphony Randomized Controlled Trial in an investor webinar
Oct 12, 2026
๐บ๐ธ United StatesAroa Biosurgery Hosts Investor Webinar to Discuss Tissue Regeneration Pipeline and Commercial Outlook
Aroa Biosurgery (AROAF) held an investor webinar to outline its tissue regeneration technology and commercial strategy
Oct 12, 2026
UsTenon Medical Completes Convertible Debt Repayment, Shares Surge Pre-Market
Tenon Medical (TNON) completed full repayment of its convertible debt, eliminating balance sheet overhang and triggering a pre-market share surge.
Sep 11, 2026
๐ฆ๐บ AustraliaResonance Health (ASX: RHT) Posts 42% Revenue Surge in FY2026 With Positive EBITDA and Robust Pipeline
Resonance Health Ltd delivered FY2026 results with revenue surging 42%, achieving positive EBITDA for the first time, and reporting a robust commercial pipeline as its liver disease assessment technology gains global clinical traction.
Sep 5, 2026
๐บ๐ธ United StatesBoston Scientific Shares Drop After Cyberattack Disrupts Global Manufacturing
Boston Scientific (BSX) shares fell sharply after disclosing a cyberattack that disrupted global manufacturing and supply chain systems.
Aug 27, 2026
๐บ๐ธ United StatesEpisurf Medical Posts Sharply Reduced H1 2026 Loss After Pivoting From Joint Repair Tech to Property Management
Episurf Medical AB (EPIS B) reported a sharply reduced H1 2026 loss after completing its strategic pivot from joint repair medical technologies to property management, with the company now classified as a property company on Swedish exchanges.
Aug 24, 2026
๐บ๐ธ United StatesInspireMD (NSPR) Faces Value Trap Risk After Q2 Miss and Product Recall
InspireMD (NSPR) reports Q2 revenue of $1.8M, missing analyst estimates amid ongoing product recall pressures.
Aug 18, 2026
๐บ๐ธ United StatesLucid Diagnostics Q2 EPS -$0.08, Revenue $1.5M Misses as EsoGuard Reimbursement Scale-Up Continues
Lucid Diagnostics Q2 EPS of negative $0.08 and revenue of $1.5 million missed estimates for the esophageal cancer diagnostic company
Aug 14, 2026
๐บ๐ธ United StatesLENSAR Q2 EPS $0.13, Revenue $16.5M as Ophthalmology Laser Company Reports Steady Results
LENSAR Q2 EPS of $0.13 and revenue of $16.5 million were reported as GuruFocus evaluates the ophthalmology company's valuation
Aug 14, 2026
๐บ๐ธ United StatesUS Small-Cap Q2: Energous Revenue Surges 217% on FCC Certification; BioStem Technologies Raises Outlook
Energous Q2 2026 revenue surges 217% to $3.1M on FCC certification and expanded wireless charging deployments. BioStem Technologies raises full-year outlook on hospital biologics growth.
Aug 14, 2026
๐บ๐ธ United StatesJourney Medical Q2 2026: Emrosi Prescriptions Hit All-Time High, Net Loss Narrows to $300K
Journey Medical Q2 2026 Emrosi prescriptions hit all-time high with net loss narrowing to $300K. 20% sequential growth and expanding payer access signal approaching profitability inflection.
Aug 14, 2026
๐บ๐ธ United StatesUS Q2 2026 Earnings: Staar Surgical Revenue Surges 111% on China Demand; Spruce Power Returns to Profit
Staar Surgical Q2 2026 net sales surge 111% to $93.5M on China EVO Plus demand. Spruce Power returns to positive net income while managing debt maturity going concern.
Aug 14, 2026
๐บ๐ธ United StatesTELA Bio (TELA) Q2 Earnings Miss Leaves GF Score at 57/100 as Recovery Path Remains Unclear
TELA Bio (TELA) missed Q2 2026 earnings expectations, with a GuruFocus composite score of 57/100 indicating below-average financial strength and growth metrics.
Aug 11, 2026
๐บ๐ธ United StatesApyx Medical +22% on FDA Body Contouring Clearance; Rashi Peripherals Posts Record Returns on 62% Revenue Surge
Apyx Medical posts 22% revenue growth on expanded FDA clearance for body contouring; Rashi Peripherals surges 62% with record ROCE and ROE in Q1 FY27 as India tech distribution demand accelerates.
Aug 8, 2026
๐บ๐ธ United StatesQ2 2026 Multi-Sector Beat: Hyperfine +45%, Navin Fluorine PAT +108%, R Systems Record EBITDA
Hyperfine posts 45% revenue growth with 50%+ gross margins; Navin Fluorine surges 44% revenue with 108% PAT growth; R Systems reaches record EBITDA margin as Mitek raises guidance on fraud detection SaaS.
Aug 8, 2026
๐บ๐ธ United StatesArtivion Wins FDA PMA as CryoPort Hits EBITDA Breakeven: Medtech Inflection in Q2 2026
Artivion reports 9% constant currency revenue growth and FDA PMA approval for its aortic device; CryoPort achieves positive adjusted EBITDA for the first time, reaffirming guidance as cell therapy logistics scales.
Aug 8, 2026
๐บ๐ธ United StatesTCGX Acquisition Corp Prices Healthcare-Focused SPAC IPO at $10, Targeting $75 Million Raise
TCGX Acquisition Corp priced its initial public offering at $10 per unit and is targeting a $75 million raise as a healthcare-sector focused Special Purpose Acquisition Company
Aug 6, 2026
๐บ๐ธ United StatesInteger Holdings Surges 20.2% on Above-Average Volume as Positive Earnings Revisions Signal MedTech Recovery
Integer Holdings (ITGR), a specialized medical device component manufacturer, surged 20.2% on significantly above-average trading volume โ signaling strong institutional conviction behind the move.
Aug 3, 2026
๐บ๐ธ United StatesRxSight (RXST) Surges 6.1% on Above-Average Volume as Medical Device Stock Attracts Buyers
RxSight Inc. (RXST) jumped 6.1% in above-average trading volume, with investors rotating into the medical device maker as its light-adjustable lens technology gains clinical adoption momentum.
Jul 18, 2026
๐บ๐ธ United StatesAbbott Laboratories (ABT) Q2 Earnings Beat Drives 10%+ Share Surge
Abbott Q2 results broadly exceeded analyst estimates across multiple business segments, driving shares 10%+ in the market's strongest medtech response of the earnings season
Jul 17, 2026
๐บ๐ธ United StatesAbbott (ABT) Sees Significant Stock Surge of 12.5%
Abbott Laboratories (ABT) surged 12.5% in a major single-session rally reflecting strong Q2 earnings beat across diversified healthcare segments
Jul 17, 2026
๐บ๐ธ United StatesTransMedics Surges 8% to $76.90 as Organ Care Technology Demand Grows
TransMedics Group gained approximately 8% to $76.90 in active trading, with institutional interest in the organ care technology company's Organ Care System platform reflecting growing adoption at US transplant centers.
Jul 14, 2026
๐บ๐ธ United StatesConmed Surges Toward Breakout on Buyout Exploration Reports
Conmed stock surged toward technical breakout territory after reports emerged that the surgical device maker is exploring a possible sale, with medtech M&A speculation fueling a sharp single-session gain, Investor's Business Daily reports.
Jul 14, 2026
๐บ๐ธ United StatesInMode (INMD) Shareholder Demands Independent Review of CEO-Led Buyout, Cites Conflict of Interest
An InMode (INMD) shareholder challenges the CEO-led management buyout proposal, demanding independent board scrutiny on conflict-of-interest grounds and arguing the bid undervalues the aesthetic MedTech company.
Jun 27, 2026
๐บ๐ธ United StatesHyperfine (HYPR) Launches Neurosurgery Advisory Council for Swoop MRI
Hyperfine launches Neurosurgery Advisory Council to guide Swoop MRI clinical strategy.
Jun 23, 2026